| P2093 | author name string | Lin Li | |
| | Zi Xuan Wang | |
| | Feng Ying Tao | |
| P2860 | cites work | Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. | Q51746689 |
| | Clinical reliability of the 6 minute corridor walk test performed within a week of a myocardial infarction | Q80230247 |
| | Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC | Q86036426 |
| | Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new approach in liver resections | Q86122657 |
| | Management of hepatocellular carcinoma: An update | Q27860530 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review | Q28083048 |
| | Hepatocellular carcinoma | Q29615765 |
| | Hepatocellular carcinoma | Q29615841 |
| | Management of hepatocellular carcinoma | Q29616230 |
| | Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. | Q33918062 |
| | Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. | Q34168811 |
| | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study | Q34335546 |
| | Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 |
| | The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis | Q34966124 |
| | Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis. | Q35914711 |
| | Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma | Q36278698 |
| | Gender differences in health education needs and preferences of Saudis attending Riyadh Military Hospital in the Kingdom of Saudi Arabia | Q36449747 |
| | Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma | Q36821641 |
| | Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas | Q37009304 |
| | Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria | Q37039550 |
| | Psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy: a complementary approach to drug analgesia | Q37203840 |
| | Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE. | Q37987405 |
| | Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses | Q38206111 |
| | Chemoembolization and radioembolization. | Q38254703 |
| | Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer | Q38612058 |
| | Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome | Q38704781 |
| | Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma | Q39375746 |
| | Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study | Q40110698 |
| | Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. | Q40121491 |
| | Awareness of interventional radiology among patients referred to the interventional radiology department: a survey of patients in a large Canadian community hospital | Q40214124 |
| | α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. | Q45795522 |
| | Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis. | Q45982152 |
| | Anxiety, depression and quality of life after cancer diagnosis: what psychosocial variables best predict how patients adjust? | Q48643538 |
| | Factors associated with psychological characteristics in patients with hepatic malignancy before interventional procedures. | Q48697821 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2115-2121 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Journal of Pain Research | Q6295704 |
| P1476 | title | Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy | |
| P478 | volume | 11 | |